8:30 - 9:10 “Therapeutics and Vaccines for COVID-19”
Rekha Rapaka, MD, PhD
Assistant Professor of Medicine
Center for Vaccine Development and Global Health
University of Maryland School of Medicine
OBJECTIVES:
- Understand the strategies of major agents in use for
treatment ofvCOVID-19 in hospitalized patients
- Understand strategies of vaccine design against
COVID-19 and recent vaccine clinical trials
for prevention of COVID-19
9:10 - 9:50 “Diagnostic Testing Considerations for COVID and
Beyond”
Yaolin Zhou, MD
Associate Professor of Pathology
Division Chief of Molecular Pathology
Director of Quality & Test Utilization
East Carolina University Brody School of Medicine
OBJECTIVES:
- Explain the differences between analytic and clinical
sensitivity and specificity
- Identify potential sources of bias and their impact on
diagnostic accuracy
9:50 - 10:00. Break
10:00 - 10:40 “Autopsy Pathology of COVID-19: A First-Person
Perspective"
Robert F. Padera, MD, PhD
Associate Professor of Pathology
Harvard Medical School
Director, Divisions of Autopsy & Cardiovascular
Pathology
Brigham & Women’s Hospital
OBJECTIVES:
- Describe anatomic findings of COVID-19 infection
including pulmonary pathology
10:40 - 11:05 “Lung Development as a Window to
Understanding Risk and Resilience in COVID-19”
Jennifer Sucre, MD
Assistant Professor of Pediatrics
Assistant Professor of Cell & Developmental Biology
Vanderbilt University School of Medicine
OBJECTIVES:
- Characterize how differential of gene expression
during normal lung development may explain
protection of infants and children from SARS-CoV-2
infection
- Define the specific epithelial populations most
vulnerable to SARS-CoV-2 infection
- Demonstrate the use of a human lung specimen
repository to provide insight into lung development and
disease across the lifespan
11:05 - 11:30 “COVID-19 and the Heart: At a Cross-Roads of Two
Epidemics”
Sadiya S Khan, MD, MSc
Assistant Professor of Medicine & Preventive Medicine
Northwestern University Feinberg School of Medicine
OBJECTIVES:
- Identify direct and indirect myocardial injury as a
consequence of SARS-COV2 infection
- Examine cardiovascular risk factors associated with
COVID-19 outcomes
- Contextualize the population burden of the
intersection of these two interdependent epidemics
REGISTRATION DEADLINE: Tuesday, October 20, 2020 (marylandpathology.org)
Registration Fees: Member: Free; Non-member practicing physician: $50; Non-member Pathologist Assistant/Cytotechnologist: $40, Non-member trainees: $25
Ø Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Providership of the College of American Pathologists and Maryland Society of Pathologists. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.
Ø Credit Designation Statement
The College of American Pathologists designates this live educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Ø Disclaimer
The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists.
Ø SAM credit Designation Statement
Part of the activity meets the American Board of Pathology (APB) Continuing Certification (CC) requirements for Self-Assessment Modules (SAMS): 1 Credit
